# Sibel Health

> Sibel Health is a Chicago-based digital health company spun out of Northwestern University that builds clinical-grade, fully wireless wearable sensors paired with AI analytics and a cloud platform. Its flagship ANNE One system continuously tracks vital signs - heart rate, respiratory rate, temperature, SpO2, pulse and more - for patients from neonates to adults, in hospitals, at home, and in low-resource settings around the world. The mission is to deliver 'Better Health Data for All.'

- **Founded:** 2018
- **Headquarters:** Chicago, United States
- **Founders:** Steve Xu (Co-Founder & CEO (physician, Northwestern Feinberg)), John A. Rogers (Co-Founder (Northwestern materials scientist / engineer)), Ha Uk Chung (Co-Founder), Jong Yoon Lee (Co-Founder)
- **Team size:** ~120 employees
- **Products:** ANNE One, ANNE Maternal, ANNE Chest / ANNE Limb, Discovery, ADAM / edema sensor
- **Notable:** Seven FDA 510(k) clearances for its wearable monitoring platforms, One of the first medical devices FDA-cleared following the IEEE 11073 SDC interoperability standard, Raised ~$108M total funding including a $39M Series C

## Products & services

- **ANNE One** — Flagship FDA-cleared wireless monitoring platform combining soft wearable sensors (ANNE Chest, ANNE Limb), a mobile app and cloud, for continuous vital signs in patients 12 and older - heart rate, respiratory rate, temperature, SpO2, pulse rate, step and fall counts.
- **ANNE Maternal** — FDA-cleared, fully wireless maternal-fetal monitoring platform for labor and delivery, deployed in low- and middle-income countries to reduce obstetric morbidity and mortality.
- **ANNE Chest / ANNE Limb** — The two soft, skin-interfaced sensors at the core of ANNE One - the chest unit captures cardiac and respiratory metrics, the limb unit captures skin and body temperature and oxygenation.
- **Discovery** — A platform used by leading pharmaceutical companies for continuous, at-home data collection in decentralized clinical trials.
- **ADAM / edema sensor** — Next-generation wearable sensing including an ARPA-H-funded first-in-class wearable for continuous edema monitoring.

## Achievements

- Seven FDA 510(k) clearances for its wearable monitoring platforms
- One of the first medical devices FDA-cleared following the IEEE 11073 SDC interoperability standard
- Raised ~$108M total funding including a $39M Series C
- Received $17.5M+ from the Gates Foundation for maternal monitoring in low-resource settings
- Featured in the Gates Foundation annual letter
- ANNE Maternal deployed across four countries (India, Pakistan, Nigeria, Rwanda)
- Awarded a $3.5M ARPA-H contract for a first-in-class continuous edema-monitoring wearable
- U.S. Department of Defense award for wearable COVID-19 early-detection sensors
- Red Dot Design Award recognition for the design team

## Latest updates

- **2025-10** — Extended Series C to $39M with new investors Maruho and Samsung Next; appointed Kimberly Querrey as Chairwoman and Tim Sullivan to the board.
- **2025-03** — Closed $30M Series C led by Steele Foundation for Hope with Drager; announced seventh FDA clearance enabling alarms, alerts and a central station for ANNE One.
- **2025** — Received FDA clearance for ANNE Maternal, a fully wireless maternal-fetal monitoring platform.
- **2025** — Awarded a $3.5M ARPA-H Direct-to-Phase-II SBIR contract for a continuous edema-monitoring wearable.

## Links

- Website: https://sibelhealth.com
- LinkedIn: http://www.linkedin.com/company/sibel-health
- Twitter/X: https://twitter.com/Sibel_Health
- Instagram: https://www.instagram.com/sibel_health/
- Facebook: https://facebook.com/sibelhealth/

---

Profile page: https://yespress.io/sibel-health
Published by YesPress — https://yespress.io
Last updated: 2026-06-12